Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | BAALC |
| Upstream (Parents) |
|---|
| (<<) ATP2C2 → BAALC |
| (<<) BCL6 → BAALC |
| (<<) CBS → BAALC |
| (<<) CXADR → BAALC |
| (<<) EPHB2 → BAALC |
| (<<) FGFBP1 → BAALC |
| (<<) FNDC4 → BAALC |
| (<<) GDF15 → BAALC |
| (<<) GPX3 → BAALC |
| (<<) NR3C1 → BAALC |
| (<<) PIK3C2B → BAALC |
| (<<) PNPLA3 → BAALC |
| (<<) PRKCD → BAALC |
| (<<) SF3A2 → BAALC |
| (<<) SOX9 → BAALC |
| (<<) TSG101 → BAALC |
| (<<) TUBA1C → BAALC |
| Downstream (Children) |
|---|
| BAALC → CEND1 (>>) |
| BAALC → GNAS (>>) |
| BAALC → NBL1 (>>) |
| BAALC → PTPN11 (>>) |
